Patents by Inventor Alexander Zukiwski

Alexander Zukiwski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Onapristone extended-release compositions and methods
    Patent number: 11672762
    Abstract: Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: June 13, 2023
    Assignee: CONTEXT BIOPHARMA, INC.
    Inventors: Alexander Zukiwski, Stefan Proniuk
  • ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS
    Publication number: 20230157960
    Abstract: Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects.
    Type: Application
    Filed: January 9, 2023
    Publication date: May 25, 2023
    Inventors: Alexander Zukiwski, Stefan Proniuk
  • ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS
    Publication number: 20210220279
    Abstract: Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects.
    Type: Application
    Filed: September 28, 2020
    Publication date: July 22, 2021
    Inventors: Alexander Zukiwski, Stefan Proniuk
  • Onapristone extended-release compositions and methods
    Patent number: 10786461
    Abstract: Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects.
    Type: Grant
    Filed: November 16, 2015
    Date of Patent: September 29, 2020
    Assignee: CONTEXT BIOPHARMA INC.
    Inventors: Alexander Zukiwski, Stefan Proniuk
  • Compositions and methods for inhibiting the growth of neisseria gonorrhoeae
    Patent number: 10201526
    Abstract: Compositions and methods for preventing and treating Neisseria gonorrhoeae infection with AR-12 alone or in combination with antibiotics are provided.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: February 12, 2019
    Assignees: Research Institute at Nationwide Children's Hospital, Ohio State Innovation Foundation
    Inventors: Jennifer Edwards, Alexander Zukiwski
  • Compositions and methods for reducing prion levels
    Patent number: 9974771
    Abstract: Compositions and methods for reducing the level of prions in a prion-infected cells or host by exposing prion infected cells, tissues and organs to AR-12 and the AR-12 analog AR-14 to reduce the prion level by at least about 90%.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: May 22, 2018
    Assignees: OHIO STATE INNOVATION FOUNDATION, UTI LIMITED PARTNERSHIP
    Inventors: Hermann M. Schaetzl, Basant Abdulrahman, Sabine Gilch, Alexander Zukiwski, Stefan Proniuk
  • COMPOSITIONS AND METHODS FOR REDUCING PRION LEVELS
    Publication number: 20170326108
    Abstract: Compositions and methods for reducing the level of prions in a prion-infected cells or host by exposing prion infected cells, tissues and organs to AR-12 and the AR-12 analog AR-14 to reduce the prion level by at least about 90%.
    Type: Application
    Filed: February 28, 2017
    Publication date: November 16, 2017
    Inventors: Hermann M. Schaetzl, Basant Abdulrahman, Sabine Gilch, Alexander Zukiwski, Stefan Proniuk
  • COMPOSITIONS AND METHODS FOR INHIBITING THE GROWTH OF NEISSERIA GONORRHOEAE
    Publication number: 20170087130
    Abstract: Compositions and methods for preventing and treating Neisseria gonorrhoeae infection with AR-12 alone or in combination with antibiotics are provided.
    Type: Application
    Filed: September 26, 2016
    Publication date: March 30, 2017
    Inventors: Jennifer Edwards, Alexander Zukiwski
  • COMPOSITIONS AND METHODS FOR INHIBITING VIRAL INFECTION
    Publication number: 20160213647
    Abstract: Compositions and methods for inhibiting viral protein production, viral infection, and viral replication in a host or host cells infected with a virus (e.g., influenza, Junin, Chikungunya, Dengue, HIV, RHDV) by administering AR-12 and AR-12 analogs are provided.
    Type: Application
    Filed: January 27, 2016
    Publication date: July 28, 2016
    Inventors: Larry Schlesinger, Jacob Yount, Alexander Zukiwski, Stefan Proniuk, María Jesús Tuñón, Keivan Zandi
  • COMPOSITIONS AND METHODS FOR INHIBITING FUNGAL INFECTIONS
    Publication number: 20160199351
    Abstract: Compositions and methods for inhibiting fungal growth by administering AR-12 to a host infected with a fungus such as Histoplasma capsulatum, Aspergillus fumigatus, and Trichophyton rubrum, Paecilomyces, Rhizopus, Fusarium, Scedosporium, Lomentospora, Apophysomyces, Coccidioides, Blastomyces, non-albicans Candida, and Pneumocytis are provided.
    Type: Application
    Filed: January 7, 2016
    Publication date: July 14, 2016
    Inventors: Chad A. Rappleye, Alexander Zukiwski, Stefan Proniuk
  • ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS
    Publication number: 20160166583
    Abstract: Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects.
    Type: Application
    Filed: November 16, 2015
    Publication date: June 16, 2016
    Inventors: Alexander Zukiwski, Stefan Proniuk
  • SYSTEMS AND METHODS FOR IDENTIFYING PROGESTERONE RECEPTOR SUBTYPES
    Publication number: 20150285803
    Abstract: Systems and methods for identifying progesterone positive tumors utilizing progesterone receptor isotype-specific antibodies are provided.
    Type: Application
    Filed: April 7, 2015
    Publication date: October 8, 2015
    Applicants: INVIVIS PHARMACEUTICALS INC., ARNO THERAPEUTICS, INC.
    Inventors: Erard Gilles, Alexander Zukiwski